- Open Access
Correction to: Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons
Journal of Translational Medicinevolume 16, Article number: 39 (2018)
The original article was published in Journal of Translational Medicine 2018 16:24
Correction to: J Transl Med (2018) 16:24 https://doi.org/10.1186/s12967-018-1392-z
The original version of this article , published on 6 February 2018, contains a mistake in the ‘Conclusions’ section. The corrected version of the affected sentence is given below and the corrected part is marked in bold.
It is unclear whether the reduction in Streptococcus is particularly beneficial in some ME/CFS patients or whether other concurrent microbial shifts are equally or more valuable (i.e., increased Bacteroides and/or reduced Clostridium).
Wallis A, Ball M, Butt H, Lewis DP, McKechnie S, Paull P, Jaa-Kwee A, Bruck D. Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons. J Transl Med. 2018;16:24. https://doi.org/10.1186/s12967-018-1392-z.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original article can be found online at https://doi.org/10.1186/s12967-018-1392-z.